Answers are grounded in this paper and cite their sources.
Canine mesotheliomas are uncommon malignant tumors typically detected late. Minimally invasive diagnostic biomarkers would facilitate diagnosis at earlier stages, thereby improving clinical outcomes. We hypothesized that mesothelin could be used as a reliable diagnostic biomarker for canine mesotheliomas since it has been used as a cancer biomarker for human mesothelioma. We aimed to explore and characterize mesothelin gene expression in dogs and assess its use as a diagnostic biomarker for canine mesotheliomas.
No takes yet. Share an insight, caveat, or question.
Nabeta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: